BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 22614618)

  • 1. The importance of the endothelium in atherothrombosis and coronary stenting.
    Otsuka F; Finn AV; Yazdani SK; Nakano M; Kolodgie FD; Virmani R
    Nat Rev Cardiol; 2012 May; 9(8):439-53. PubMed ID: 22614618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.
    Inoue T; Croce K; Morooka T; Sakuma M; Node K; Simon DI
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1057-66. PubMed ID: 22017929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].
    Koziński M; Sukiennik A; Sinkiewicz W; Kochman W; Kubica J
    Postepy Hig Med Dosw (Online); 2008 May; 62():185-205. PubMed ID: 18464681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge.
    Borovac JA; D'Amario D; Vergallo R; Porto I; Bisignani A; Galli M; Annibali G; Montone RA; Leone AM; Niccoli G; Crea F
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):105-116. PubMed ID: 30285099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Stents in interventional cardiology].
    Grinius V; Navickas R; Unikas R
    Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.
    Dangas GD; Caixeta A; Mehran R; Parise H; Lansky AJ; Cristea E; Brodie BR; Witzenbichler B; Guagliumi G; Peruga JZ; Dudek D; Möeckel M; Stone GW;
    Circulation; 2011 Apr; 123(16):1745-56. PubMed ID: 21482968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of early, late, and very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction.
    Brodie B; Pokharel Y; Garg A; Kissling G; Hansen C; Milks S; Cooper M; McAlhany C; Stuckey T
    JACC Cardiovasc Interv; 2012 Oct; 5(10):1043-51. PubMed ID: 23078734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.
    Torrado J; Buckley L; Durán A; Trujillo P; Toldo S; Valle Raleigh J; Abbate A; Biondi-Zoccai G; Guzmán LA
    J Am Coll Cardiol; 2018 Apr; 71(15):1676-1695. PubMed ID: 29650125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular responses to drug eluting stents: importance of delayed healing.
    Finn AV; Nakazawa G; Joner M; Kolodgie FD; Mont EK; Gold HK; Virmani R
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1500-10. PubMed ID: 17510464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genous™ endothelial progenitor cell capture stent accelerates stent re-endothelialization but does not affect intimal hyperplasia in porcine coronary arteries.
    van Beusekom HM; Ertaş G; Sorop O; Serruys PW; van der Giessen WJ
    Catheter Cardiovasc Interv; 2012 Feb; 79(2):231-42. PubMed ID: 21834062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.
    Malenka DJ; Kaplan AV; Lucas FL; Sharp SM; Skinner JS
    JAMA; 2008 Jun; 299(24):2868-76. PubMed ID: 18577731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.
    Byrne RA; Joner M; Kastrati A
    Eur Heart J; 2015 Dec; 36(47):3320-31. PubMed ID: 26417060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification.
    Douglas G; Van Kampen E; Hale AB; McNeill E; Patel J; Crabtree MJ; Ali Z; Hoerr RA; Alp NJ; Channon KM
    Eur Heart J; 2013 Nov; 34(43):3378-88. PubMed ID: 23008511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.